Beijing Strong Biotechnologies, Inc. (300406.SZ)
CNY 14.39
(0.7%)
CNY 14.39
(0.7%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.13 Billion CNY | 3.0% |
| 2022 | 1.1 Billion CNY | -1.96% |
| 2021 | 1.12 Billion CNY | 274.69% |
| 2020 | 300.11 Million CNY | 234.12% |
| 2019 | 89.82 Million CNY | 40.39% |
| 2018 | 63.98 Million CNY | 3.73% |
| 2017 | 61.67 Million CNY | 198.26% |
| 2016 | 20.67 Million CNY | -21.98% |
| 2015 | 26.5 Million CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | -100.0% |
| 2012 | 5 Million CNY | 0.0% |
| 2011 | 5 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 1.16 Billion CNY | 2.92% |
| 2024 Q3 | 1.16 Billion CNY | -3.71% |
| 2024 Q2 | 1.21 Billion CNY | 3.72% |
| 2023 Q3 | 1.12 Billion CNY | -1.05% |
| 2023 Q4 | 1.13 Billion CNY | 1.01% |
| 2023 Q1 | 1.11 Billion CNY | 1.25% |
| 2023 Q2 | 1.13 Billion CNY | 1.78% |
| 2023 FY | 1.13 Billion CNY | 3.0% |
| 2022 Q4 | 1.1 Billion CNY | -3.42% |
| 2022 FY | 1.1 Billion CNY | -1.96% |
| 2022 Q2 | 1.07 Billion CNY | 0.24% |
| 2022 Q1 | 1.07 Billion CNY | -4.49% |
| 2022 Q3 | 1.14 Billion CNY | 6.04% |
| 2021 Q4 | 1.12 Billion CNY | 53.93% |
| 2021 Q1 | 281.05 Million CNY | -6.35% |
| 2021 Q2 | 281.06 Million CNY | 0.0% |
| 2021 FY | 1.12 Billion CNY | 274.69% |
| 2021 Q3 | 730.54 Million CNY | 159.92% |
| 2020 Q4 | 300.11 Million CNY | -0.54% |
| 2020 Q3 | 301.74 Million CNY | 50.16% |
| 2020 Q2 | 200.95 Million CNY | 32.09% |
| 2020 Q1 | 152.13 Million CNY | 69.37% |
| 2020 FY | 300.11 Million CNY | 234.12% |
| 2019 Q2 | 6.13 Million CNY | 1.0% |
| 2019 Q4 | 89.82 Million CNY | 1348.71% |
| 2019 Q1 | 6.07 Million CNY | -90.5% |
| 2019 FY | 89.82 Million CNY | 40.39% |
| 2019 Q3 | 6.2 Million CNY | 1.0% |
| 2018 Q3 | 62.74 Million CNY | 0.44% |
| 2018 FY | 63.98 Million CNY | 3.73% |
| 2018 Q4 | 63.98 Million CNY | 1.98% |
| 2018 Q2 | 62.46 Million CNY | -7.72% |
| 2018 Q1 | 67.68 Million CNY | 9.74% |
| 2017 Q3 | - CNY | 0.0% |
| 2017 Q4 | 61.67 Million CNY | 0.0% |
| 2017 FY | 61.67 Million CNY | 198.26% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2016 Q2 | - CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2016 FY | 20.67 Million CNY | -21.98% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 Q3 | - CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2015 Q3 | - CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 FY | 26.5 Million CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2013 Q4 | - CNY | 0.0% |
| 2013 FY | - CNY | -100.0% |
| 2012 FY | 5 Million CNY | 0.0% |
| 2011 FY | 5 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Dian Diagnostics Group Co.,Ltd. | 4.29 Billion CNY | 73.539% |
| Hangzhou Tigermed Consulting Co., Ltd. | 3.34 Billion CNY | 66.066% |
| Dirui Industrial Co.,Ltd. | 714.1 Million CNY | -59.027% |
| Medicalsystem Biotechnology Co., Ltd. | 108.17 Million CNY | -949.841% |
| Maccura Biotechnology Co.Ltd | 665.16 Million CNY | -70.729% |
| Guangzhou Wondfo Biotech Co.,Ltd | 599.53 Million CNY | -89.417% |
| Guangdong Hybribio Biotech Co.,Ltd. | 56.65 Million CNY | -1904.549% |
| BGI Genomics Co., Ltd. | 1.09 Billion CNY | -3.577% |
| Amoy Diagnostics Co., Ltd. | 108.34 Million CNY | -948.145% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | 374.62 Million CNY | -203.139% |